Bisaryl cyclobutenes derivatives as cyclooxygenase inhibitors
申请人:Merck Frosst Canada, Inc.
公开号:US05817700A1
公开(公告)日:1998-10-06
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.